HEADER OXIDOREDUCTASE 12-MAR-09 2KGK TITLE SOLUTION STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS ANTHRACIS; SOURCE 3 ORGANISM_COMMON: ANTHRAX,ANTHRAX BACTERIUM; SOURCE 4 ORGANISM_TAXID: 1392; SOURCE 5 GENE: DFRA, BAS2083, BA_2237, GBAA2237; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET 41 KEYWDS DHFR, OXIDOREDUCTASE EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR L.DESHMUKH,O.VINOGRADOVA,J.M.BEIERLEIN,K.M.FREY,A.C.ANDERSON REVDAT 4 22-MAY-24 2KGK 1 REMARK REVDAT 3 16-MAR-22 2KGK 1 REMARK REVDAT 2 26-MAY-09 2KGK 1 JRNL REVDAT 1 12-MAY-09 2KGK 0 JRNL AUTH J.M.BEIERLEIN,L.DESHMUKH,K.M.FREY,O.VINOGRADOVA,A.C.ANDERSON JRNL TITL THE SOLUTION STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE JRNL TITL 2 REDUCTASE YIELDS INSIGHT INTO THE ANALYSIS OF JRNL TITL 3 STRUCTURE-ACTIVITY RELATIONSHIPS FOR NOVEL INHIBITORS. JRNL REF BIOCHEMISTRY V. 48 4100 2009 JRNL REFN ISSN 0006-2960 JRNL PMID 19323450 JRNL DOI 10.1021/BI802319W REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 2.20 REMARK 3 AUTHORS : SCHWIETERS, C. ET AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KGK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000101093. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 13C; U-100% 15N] REMARK 210 DHFR, 2 MM UCP120B, 2 MM NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE REMARK 210 PHOSPHATE, 0.5 MM EDTA, 10 MM DTT, 50 MM POTASSIUM CHLORIDE, 20 REMARK 210 MM TES, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 HCCH-TOCSY; 3D HNCO; 3D HBHA(CO) REMARK 210 NH; 3D C(CO)NH; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.1 REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 LEU A 163 REMARK 465 GLU A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 HIS A 167 REMARK 465 HIS A 168 REMARK 465 HIS A 169 REMARK 465 HIS A 170 REMARK 465 HIS A 171 REMARK 465 HIS A 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H GLY A 44 HD22 ASN A 47 1.27 REMARK 500 O ASN A 12 HE ARG A 13 1.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 13 -132.31 -134.78 REMARK 500 1 VAL A 14 -42.08 -154.04 REMARK 500 1 ILE A 15 -45.85 -152.80 REMARK 500 1 ASP A 18 70.56 -168.13 REMARK 500 1 ASN A 19 -15.74 74.99 REMARK 500 1 PRO A 22 -161.24 -57.10 REMARK 500 1 LEU A 25 66.17 38.43 REMARK 500 1 MET A 37 110.45 -33.67 REMARK 500 1 ARG A 53 138.58 55.01 REMARK 500 1 PRO A 54 -85.03 -74.25 REMARK 500 1 LEU A 55 61.44 -152.93 REMARK 500 1 ARG A 58 17.78 54.08 REMARK 500 1 ARG A 59 60.79 -151.03 REMARK 500 1 ASN A 66 92.77 179.20 REMARK 500 1 SER A 79 -173.90 -56.66 REMARK 500 1 GLU A 91 -79.64 -48.66 REMARK 500 1 HIS A 118 50.64 -95.67 REMARK 500 1 HIS A 119 113.61 -165.88 REMARK 500 1 GLU A 122 106.25 44.20 REMARK 500 1 PHE A 127 95.93 -165.66 REMARK 500 1 GLU A 129 94.56 -59.48 REMARK 500 1 LEU A 144 147.25 -170.36 REMARK 500 1 THR A 145 -179.63 -58.53 REMARK 500 1 PRO A 150 34.01 -75.25 REMARK 500 2 ARG A 13 -114.05 -142.00 REMARK 500 2 VAL A 14 -41.15 -164.38 REMARK 500 2 ILE A 15 -48.99 -159.68 REMARK 500 2 ASP A 18 76.99 -159.28 REMARK 500 2 ASN A 20 -171.58 -170.36 REMARK 500 2 PRO A 26 -18.43 -41.61 REMARK 500 2 MET A 37 152.06 -36.95 REMARK 500 2 PRO A 56 109.70 -49.49 REMARK 500 2 ARG A 59 58.00 -159.92 REMARK 500 2 ASN A 66 85.73 172.09 REMARK 500 2 SER A 79 -175.83 -62.40 REMARK 500 2 HIS A 119 112.50 -163.19 REMARK 500 2 ALA A 120 140.65 -170.02 REMARK 500 2 GLU A 122 110.44 27.84 REMARK 500 2 PRO A 128 -163.53 -72.09 REMARK 500 2 MET A 130 -55.01 -129.70 REMARK 500 2 PRO A 150 32.29 -78.46 REMARK 500 3 ARG A 13 -137.08 -135.51 REMARK 500 3 VAL A 14 -39.18 -136.75 REMARK 500 3 ILE A 15 -55.61 -161.72 REMARK 500 3 ASP A 18 77.73 -179.66 REMARK 500 3 ASN A 19 -5.98 68.49 REMARK 500 3 ASN A 20 -165.04 -169.26 REMARK 500 3 ARG A 24 -167.54 -129.88 REMARK 500 3 PRO A 54 -166.58 -76.02 REMARK 500 3 PRO A 56 2.78 -69.38 REMARK 500 REMARK 500 THIS ENTRY HAS 304 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 173 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N22 A 174 DBREF 2KGK A 1 162 UNP Q81R22 Q81R22_BACAN 1 162 SEQRES 1 A 172 MET ILE VAL SER PHE MET VAL ALA MET ASP GLU ASN ARG SEQRES 2 A 172 VAL ILE GLY LYS ASP ASN ASN LEU PRO TRP ARG LEU PRO SEQRES 3 A 172 SER GLU LEU GLN TYR VAL LYS LYS THR THR MET GLY HIS SEQRES 4 A 172 PRO LEU ILE MET GLY ARG LYS ASN TYR GLU ALA ILE GLY SEQRES 5 A 172 ARG PRO LEU PRO GLY ARG ARG ASN ILE ILE VAL THR ARG SEQRES 6 A 172 ASN GLU GLY TYR HIS VAL GLU GLY CYS GLU VAL ALA HIS SEQRES 7 A 172 SER VAL GLU GLU VAL PHE GLU LEU CYS LYS ASN GLU GLU SEQRES 8 A 172 GLU ILE PHE ILE PHE GLY GLY ALA GLN ILE TYR ASP LEU SEQRES 9 A 172 PHE LEU PRO TYR VAL ASP LYS LEU TYR ILE THR LYS ILE SEQRES 10 A 172 HIS HIS ALA PHE GLU GLY ASP THR PHE PHE PRO GLU MET SEQRES 11 A 172 ASP MET THR ASN TRP LYS GLU VAL PHE VAL GLU LYS GLY SEQRES 12 A 172 LEU THR ASP GLU LYS ASN PRO TYR THR TYR TYR TYR HIS SEQRES 13 A 172 VAL TYR GLU LYS GLN GLN LEU GLU HIS HIS HIS HIS HIS SEQRES 14 A 172 HIS HIS HIS HET NAP A 173 54 HET N22 A 174 27 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM N22 5-[3-(2,5-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6- HETNAM 2 N22 ETHYLPYRIMIDINE-2,4-DIAMINE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 N22 C17 H20 N4 O2 HELIX 1 1 LEU A 25 MET A 37 1 13 HELIX 2 2 ARG A 45 GLY A 52 1 8 HELIX 3 3 LEU A 55 ARG A 58 5 4 HELIX 4 4 SER A 79 LYS A 88 1 10 HELIX 5 5 GLY A 98 PHE A 105 1 8 SHEET 1 A 8 GLU A 75 ALA A 77 0 SHEET 2 A 8 ASN A 60 VAL A 63 1 N ILE A 62 O GLU A 75 SHEET 3 A 8 LEU A 41 GLY A 44 1 N LEU A 41 O ILE A 61 SHEET 4 A 8 GLU A 92 GLY A 97 1 O PHE A 96 N ILE A 42 SHEET 5 A 8 ILE A 2 ASP A 10 1 N SER A 4 O ILE A 93 SHEET 6 A 8 LYS A 111 ILE A 117 1 O ILE A 117 N MET A 9 SHEET 7 A 8 TYR A 153 GLU A 159 -1 O TYR A 158 N LEU A 112 SHEET 8 A 8 LYS A 136 LYS A 142 -1 N GLU A 141 O TYR A 155 SITE 1 AC1 18 ALA A 8 ILE A 15 ASN A 19 ASN A 20 SITE 2 AC1 18 LEU A 21 ARG A 45 LYS A 46 ASN A 47 SITE 3 AC1 18 THR A 64 ARG A 65 SER A 79 PHE A 96 SITE 4 AC1 18 GLY A 97 GLY A 98 ALA A 99 GLN A 100 SITE 5 AC1 18 ILE A 101 THR A 125 SITE 1 AC2 8 LEU A 21 PRO A 22 TRP A 23 ARG A 24 SITE 2 AC2 8 VAL A 32 ILE A 51 ARG A 53 PHE A 96 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1